Ferreira Edilene Bega, de Assis Rocha Neves Francisco, da Costa Marlom Anselmo, do Prado Wilson Alves, de Araújo Funari Ferri Letícia, Bazotte Roberto Barbosa
Department of Pharmacy and Pharmacology, State University of Maringá, Maringá-Pr, Brazil.
Planta Med. 2006 Jun;72(8):691-6. doi: 10.1055/s-2006-931586. Epub 2006 May 29.
The purpose of the present study was to compare the effect of the oral treatment (gavage) with Stevia rebaudiana (Bert.) Bertoni (SRB) and stevioside (STV) on glycaemia and gluconeogenesis of 15-h fasted rats. For this purpose, the rats received SRB (20 mg/kg x day), STV (5.5 mg/kg x day) or an equal volume of water (controls) during 15 days. To measure hepatic gluconeogenesis, liver perfusion and isolated hepatocytes were used. Glycaemia and gluconeogenesis from L-alanine (5 mM), L-glutamine (5 mM) and L-lactate (2 mM) were decreased (P < 0.05) after pre-treatment with SRB. However, the treatment with STV did not influence glycaemia and gluconeogenesis. Moreover, to get further information about the mechanism by which SRB leaves inhibit gluconeogenesis their potential role as a PPARgamma agonist was investigated. The data showed absence of activation of PPARgamma receptors. In summary, our results showed that the reduction of glycaemia promoted by the treatment with SRB leaves was mediated, at least in part, by an inhibition of hepatic gluconeogenesis. However, this effect did not involve stevioside and the activation of PPARgamma receptors.
本研究的目的是比较用甜叶菊(Stevia rebaudiana (Bert.) Bertoni,SRB)和甜菊糖苷(stevioside,STV)对禁食15小时的大鼠进行口服治疗(灌胃)对血糖和糖异生的影响。为此,大鼠在15天内接受SRB(20毫克/千克×天)、STV(5.5毫克/千克×天)或等体积的水(对照组)。为了测量肝脏糖异生,采用了肝脏灌注和分离的肝细胞。用SRB预处理后,来自L-丙氨酸(5毫摩尔)、L-谷氨酰胺(5毫摩尔)和L-乳酸(2毫摩尔)的血糖和糖异生降低(P<0.05)。然而,用STV治疗不影响血糖和糖异生。此外,为了进一步了解SRB叶抑制糖异生的机制,研究了它们作为PPARγ激动剂的潜在作用。数据显示PPARγ受体未被激活。总之,我们的结果表明,用SRB叶治疗促进的血糖降低至少部分是由肝脏糖异生的抑制介导的。然而,这种作用不涉及甜菊糖苷和PPARγ受体的激活。